Literature DB >> 2444458

S protein/vitronectin in chronic liver diseases: correlations with serum cholinesterase, coagulation factor X and complement component C3.

B Kemkes-Matthes1, K T Preissner, F Langenscheidt, K J Matthes, G Müller-Berghaus.   

Abstract

S protein/vitronectin plays an important role as a regulatory component in the terminal steps of the complement- and coagulation cascades. In patients suffering from chronic liver diseases, plasma S protein concentration was measured and compared with changes in serum cholinesterase activity, coagulation factor X activity and complement component C3 concentration. Significant decreases of all these proteins were seen in liver cirrhosis. Changes in S protein concentration correlated closely with those of cholinesterase, factor X and complement C3. The data give support for the liver as the main organ of plasma S protein/vitronectin synthesis.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2444458     DOI： 10.1111/j.1600-0609.1987.tb00747.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


  10 in total

1.  Increased levels of plasma vitronectin in severe psoriatic patients.

Authors:  T Nogita; M Kawashima
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

3.  Activation of blood coagulation and fibrinolysis in vibration syndrome.

Authors:  R Shunto; A Shirakami; A Ohara; N Toibana; S Saito
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

4.  Serum vitronectin concentration in various liver diseases.

Authors:  K Okabe
Journal:  Gastroenterol Jpn       Date:  1989-02

Review 5.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

6.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

7.  Low levels of serum vitronectin associated with clinical phases in patients with hemorrhagic fever with renal syndrome.

Authors:  Zhengwen Liu; Qunying Han; Lei Zhang; Qianzi Zhao; Jinghong Chen; Sai Lou
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

8.  Evidence that extrahepatic cells express vitronectin mRNA at rates approaching those of hepatocytes.

Authors:  D Seiffert; G M Bordin; D J Loskutoff
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

9.  Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.

Authors:  D Seiffert; N N Wagner; D J Loskutoff
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

10.  Serum butyrylcholinesterase predicts survival after extracorporeal membrane oxygenation after cardiovascular surgery.

Authors:  Klaus Distelmaier; Max-Paul Winter; Kurt Rützler; Gottfried Heinz; Irene M Lang; Gerald Maurer; Herbert Koinig; Barbara Steinlechner; Alexander Niessner; Georg Goliasch
Journal:  Crit Care       Date:  2014-01-30       Impact factor: 9.097
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.